Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer

Purpose: In this single institution retrospective study of patients with stage I medically inoperable non-small cell lung cancer (NSCLC) treated with stereotactic ablative radiotherapy (SABR) we attempt to model overall survival (OS) using initial prognostic variables with specific attention on the...

Full description

Bibliographic Details
Main Authors: Oliver Edwin Holmes, Robert MacRae, Graham Cook, Peter Cross, Vimoj Nair, Horia Marginean, Jason R. Pantarotto
Format: Article
Language:English
Published: Elsevier 2017-08-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Charlson Comorbidity Index
SABR
Non-small cell lung cancer
Medically inoperable
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630817300010

Internet

http://www.sciencedirect.com/science/article/pii/S2405630817300010

Similar Items